MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis

Nature Reviews Rheumatology

Volumn 8, Issue 12, 2012, Pages 701-709

  Shen, Nan ^a   Liang, Dong ^b   Tang, Yuanjia ^a   De Vries, Niek ^c   Tak, Paul Peter ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; DNA; DNA METHYLTRANSFERASE 1; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 13; MICRORNA; MICRORNA 146A; MICRORNA 155; RANTES; STAT PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BLOOD CELL; BODY FLUID; CELL MATURATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DNA METHYLATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MEDICAL ASSESSMENT; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, CELLULAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS;

EID: 84870684707     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2012.142     Document Type: Review

References (112)

1. Bartel, D. P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
2. Carrington, J. C. & Ambros, V. Role of microRNAs in plant and animal development. Science 301, 336-338 (2003).
3. Xiao, C. & Rajewsky, K. MicroRNA control in the immune system: Basic principles. Cell 136, 26-36 (2009).
4. Inui, M., Martello, G. & Piccolo, S. MicroRNA control of signal transduction. Nat. Rev. Mol. Cell. Biol. 11, 252-263 (2010).
5. Luo, X., Tsai, L. M., Shen, N. & Yu, D. Evidence for microRNA-mediated regulation in rheumatic diseases. Ann. Rheum. Dis. 69 (Suppl. 1), i30-i36 (2010).
6. Bentwich, I. et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37, 766-770 (2005).
7. Asirvatham, A. J., Gregorie, C. J., Hu, Z., Magner, W. J. & Tomasi, T. B. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol. Immunol. 45, 1995-2006 (2008).
8. Fairhurst, A. M., Wandstrat, A. E. & Wakeland, E. K. Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv. Immunol. 92, 1-69 (2006).
9. Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L. & Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902-1910 (2004).
10. Saini, H. K., Griffiths-Jones, S. & Enright, A. J. Genomic analysis of human microRNA transcripts. Proc. Natl Acad. Sci. USA 104, 17719-17724 (2007).
11. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840 (2010).
12. Diederichs, S. & Haber, D. A. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131, 1097-1108 (2007).
13. Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655 (2009).
14. Kim, V. N., Han, J. & Siomi, M. C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell. Biol. 10, 126-139 (2009).
15. Zhou, H. et al. miR 155 and its star-form partner miR 155 cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 116, 5885-5894 (2010).
16. Sun, Y. et al. Targeting of microRNA 142 3p in dendritic cells regulates endotoxin-induced mortality. Blood 117, 6172-6183 (2011).
17. Okamura, K., Hagen, J. W., Duan, H., Tyler, D. M. & Lai, E. C. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130, 89-100 (2007).
18. Ruby, J. G., Jan, C. H. & Bartel, D. P. Intronic microRNA precursors that bypass Drosha processing. Nature 448, 83-86 (2007).
19. Yang, J. S. & Lai, E. C. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol. Cell 43, 892-903 (2011).
20. Yang, J. S. & Lai, E. C. Dicer-independent, Ago2-mediated microRNA biogenesis in vertebrates. Cell Cycle 9, 4455-4460 (2010).
21. Jakymiw, A. et al. Autoimmune targeting of key components of RNA interference. Arthritis Res. Ther. 8, R87 (2006).
22. Ruggiero, T. et al. LPS induces KH type splicing regulatory protein-dependent processing of microRNA 155 precursors in macrophages. FASEB 23, 2898-2908 (2009).
23. Wiesen, J. L. & Tomasi, T. B. Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 46, 1222-1228 (2009).
24. Cameron, J. E. et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 382, 257-266 (2008).
25. Godshalk, S. E., Bhaduri-McIntosh, S. & Slack, F. J. Epstein-Barr virus-mediated dysregulation of human microRNA expression. Cell Cycle 7, 3595-3600 (2008).
26. Dai, R. et al. Suppression of LPS-induced Interferon-γ and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: A novel mechanism of immune modulation. Blood 112, 4591-4597 (2008).
27. Pauley, K. M., Cha, S. & Chan, E. K. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 32, 189-194 (2009).
28. O'Neill, L. A., Sheedy, F. J. & McCoy, C. E. MicroRNAs: The fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11, 163-175 (2011).
29. Nahid, M. A., Satoh, M. & Chan, E. K. MicroRNA in TLR signaling and endotoxin tolerance. Cell. Mol. Immunol. 8, 388-403 (2011).
30. Fazi, F. et al. A minicircuitry comprised of microRNA 223 and transcription factors NFI A and C/EBPα regulates human granulopoiesis. Cell 123, 819-831 (2005).
31. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA 223. Nature 451, 1125-1129 (2008).
32. Fontana, L. et al. MicroRNAs 17 5p 20a 106a control monocytopoiesis through AML1 targeting and M CSF receptor upregulation. Nat. Cell Biol. 9, 775-787 (2007).
33. Rosa, A. et al. The interplay between the master transcription factor PU.1 and miR 424 regulates human monocyte/macrophage differentiation. Proc. Natl Acad. Sci. USA 104, 19849-19854 (2007).
34. Ooi, A. G. et al. MicroRNA 125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc. Natl Acad. Sci. USA 107, 21505-21510 (2010).
35. Lal, A. et al. miR 24 mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat. Struct. Mol. Biol. 16, 492-498 (2009).
36. Stittrich, A. B. et al. The microRNA miR 182 is induced by IL 2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 11, 1057-1062 (2010).
37. Li, Q. J. et al. miR 181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129, 147-161 (2007).
38. Xiao, C. et al. MiR 150 controls B cell differentiation by targeting the transcription factor c Myb. Cell 131, 146-159 (2007).
39. Koralov, S. B. et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132, 860-874 (2008).
40. Junker, A., Hohlfeld, R. & Meinl, E. The emerging role of microRNAs in multiple sclerosis. Nat. Rev. Neurol. 7, 56-59 (2011).
41. Duroux-Richard, I., Jorgensen, C & Apparailly, F. What do microRNAs mean for rheumatoid arthritis? Arthritis Rheum. 64, 11-20 (2012).
42. Alevizos, I. & Illei, G. G. MicroRNAs as biomarkers in rheumatic diseases. Nat. Rev. Rheumatol. 6, 391-398 (2010).
43. Ceribelli, A. et al. MicroRNAs in systemic rheumatic diseases. Arthritis Res. Ther. 13, 229 (2011).
44. Nakasa, T. et al. Expression of microRNA 146 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 58, 1284-1292 (2008).
45. Stanczyk, J. et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 58, 1001-1009 (2008).
46. Liston, A., Lu, L. F., O'Carroll, D., Tarakhovsky, A. & Rudensky, A. Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J. Exp. Med. 205, 1993-2004 (2008).
47. Smith, L. K., Shah, R. R. & Cidlowski, J. A. Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J. Biol. Chem. 285, 36698-36708 (2010).
48. Biton, M. et al. Epithelial microRNAs regulate gut mucosal immunity via epithelium T cell crosstalk. Nat. Immunol. 12, 239-246 (2011).
49. Zhang, N. & Bevan, M. J. Dicer controls CD8+ T cell activation, migration, and survival. Proc. Natl Acad. Sci. USA 107, 21629-21634 (2010).
50. Thai, T. H. et al. Regulation of the germinal center response by microRNA 155. Science 316, 604-608 (2007).
51. Rodriguez, A. et al. Requirement of bic/microRNA 155 for normal immune function. Science 316, 608-611 (2007).
52. Sonkoly, E. et al. MiR 155 is overexpressed in patients with atopic dermatitis and modulates T cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J. Allergy Clin. Immunol. 126, 581-589 (2010).
53. Yao, R. et al. The altered expression of inflammation-related microRNAs with microRNA 155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell. Mol. Immunol. 8, 486-495 (2011).
54. Kurowska-Stolarska, M. et al. MicroRNA 155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl Acad. Sci. USA 108, 11193-11198 (2011).
55. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF κB dependent induction of microRNA miR 146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481-12486 (2006).
56. Nahid, M. A., Pauley, K. M., Satoh, M. & Chan, E. K. miR 146a is critical for endotoxin-induced tolerance: Implication in innate immunity. J. Biol. Chem. 284, 34590-34599 (2009).
57. Nahid, M. A., Satoh, M. & Chan, E. K. Mechanistic role of microRNA 146a in endotoxin-induced differential cross-regulation of TLR signaling. J. Immunol. 186, 1723-1734 (2011).
58. Chassin, C. et al. miR 146a mediates protective innate immune tolerance in the neonate intestine. Cell Host Microbe 8, 358-368 (2010).
59. Boldin, M. P. et al. miR 146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201 (2011).
60. Curtale, G. et al. An emerging player in the adaptive immune response: MicroRNA 146a is a modulator of IL 2 expression and activation-induced cell death in T lymphocytes. Blood 115, 265-273 (2010).
61. Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
62. Dai, Y. et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16, 939-946 (2007).
63. Tang, Y. et al. MicroRNA 146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60, 1065-1075 (2009).
64. Te, J. L. et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 5, e10344 (2010).
65. Dai, Y. et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheum. Int. 29, 749-754 (2009).
66. Stagakis, E. et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: MiR 21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann. Rheum. Dis. 70, 1496-1506 (2011).
67. Zhao, S. et al. MicroRNA 126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 63, 1376-1386 (2011).
68. Pan, W. et al. MicroRNA 21 and microRNA 148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184, 6773-6781 (2010).
69. Dai, R. et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS ONE 5, e14302 (2010).
70. Zhao, S. et al. MicroRNA 126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 63, 1376-1386 (2011).
71. Junker, A., Hohlfeld, R. & Meinl, E. The emerging role of microRNAs in multiple sclerosis. Nat. Rev. Neurol. 7, 56-59 (2011).
72. Buermans, H. P., Ariyurek, Y., van Ommen, G., den Dunnen, J. T. & Hoen, P. A. New methods for next generation sequencing based microRNA expression profiling. BMC Genomics 11, 716 (2010).
73. Shendure, J. & Ji, H. Next-generation DNA sequencing. Nat. Biotechnol. 26, 1135-1145 (2008).
74. Pauley, K. M. et al. Upregulated miR 146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 10, R101 (2008).
75. Pauley, K. M. et al. Altered miR 146a expression in Sjogren's syndrome and its functional role in innate immunity. Eur. J. Immunol. 41, 2029-2039 (2011).
76. Chan, E K., Satoh, M. & Pauley, K. M. Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: Is microRNA 146 all we need? Arthritis Rheum. 60, 912-915 (2009).
77. Hou, J. et al. MicroRNA 146a feedback inhibits RIG I dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183, 2150-2158 (2009).
78. Perry, M. M., Tsitsiou, E. & Lindsay, M. A. Increased expression of microRNA 146a negatively regulates both the LPS and Poly (I:C) induced inflammatory response in monocytes. Am. J. Crit. Care Med. 181, A2042 (2010).
79. Vaughn, S. E., Kottyan, L. C., Munroe, M. E. & Harley, J. B. Genetic susceptibility to lupus: The biological basis of genetic risk found in B cell signaling pathways. J. Leukoc. Biol. 92, 577-591 (2012).
80. Lu, L. F. et al. Function of miR 146a in controlling TREG cell-mediated regulation of TH1 responses. Cell 142, 914-929 (2010).
81. Selbach, M. et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63 (2008).
82. Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64-71 (2008).
83. Lu, Q., Shen, N., Li, X. M. & Chen, S. L. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice. Genes Immun. 8, 590-603 (2007).
84. Garzon, R. et al. MicroRNA 29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113, 6411-6418 (2009).
85. Andreopoulos, B. & Anastassiou, D. Integrated analysis reveals hsa miR 142 as a representative of a lymphocyte-specific gene expression and methylation signature. Cancer Inform. 11, 61-75 (2012).
86. Ballestar, E., Esteller, M. & Richardson, B. C. The epigenetic face of systemic lupus erythematosus. J. Immunol. 176, 7143-7147 (2006).
87. Kosco, K. A., Cerignoli, F., Williams, S., Abraham, R. T. & Mustelin, T. SKAP55 modulates T cell antigen receptor-induced activation of the Ras Erk AP1 pathway by binding RasGRP1. Mol. Immunol. 45, 510-522 (2008).
88. Chen, C. Z., Li, L., Lodish, H. F. & Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86 (2004).
89. Lieberman, L. A. & Tsokos, G. C. The IL 2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J. Biomed. Biotechnol. 2010, 740619 (2010).
90. Zhao, X. et al. MicroRNA 125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 62, 3425-3435 (2010).
91. Song, A., Chen, Y. F., Thamatrakoln, K., Storm, T. A. & Krensky, A. M. RFLAT 1: A new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes. Immunity 10, 93-103 (1999).
92. Linker-Israeli, M. et al. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 130, 2651-2655 (1983).
93. Crispin, J. C. & Tsokos, G. C. Transcriptional regulation of IL 2 in health and autoimmunity. Autoimmun. Rev. 8, 190-195 (2009).
94. Fan, W. et al. Identification of microRNA 31 as a novel regulator contributing to impaired IL 2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. http://dx.doi.org/10.1002/art.34596.
95. Valastyan, S. et al. A pleiotropically acting microRNA, miR 31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
96. Linsley, P. S. et al. Transcripts targeted by the microRNA 16 family cooperatively regulate cell cycle progression. Mol. Cell. Biol. 27, 2240-2252 (2007).
97. Helms, W. S. et al. Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells. J. Leukoc. Biol. 82, 361-369 (2007).
98. Zhu, S. et al. The microRNA miR 23b suppresses IL 17 associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat. Med. 18, 1077-1086 (2012).
99. Wilbe, M. et al. Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex. Nat. Genet. 42, 250-254 (2010).
100. Yang, W. et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 6, e1000841 (2010).
101. Gateva, V. et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228-1233 (2009).
102. Han, J. W. et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234-1237 (2009).
103. Kloosterman, W. P. & Plasterk, R. H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441-450 (2006).
104. Luo, X. et al. A functional variant in microRNA 146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 7, e1002128 (2011).
105. Lofgren, S. E. et al. Genetic association of miRNA 146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun. 13, 268-274 (2012).
106. Brest, P. et al. A synonymous variant in IRGM alters a binding site for miR 196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat. Genet. 43, 242-245 (2011).
107. Hikami, K. et al. Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus. Arthritis Rheum. 63, 755-763 (2011).
108. Vinuesa, C. G., Rigby, R. J. & Yu, D. Logic and extent of miRNA-mediated control of autoimmune gene expression. Int. Rev. Immunol. 28, 112-138 (2009).
109. Krek, A. et al. Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (2005).
110. Garchow, B. G. et al. Silencing of microR6-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol. Med. 3, 605-615 (2011).
111. Gilad, S. et al. Serum microRNAs are promising novel biomarkers. PLoS ONE 3, e3148 (2008).
112. Lee, Y. et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060 (2004).